Maria Baer MD

Oncology•Baltimore, MD

Professor of Hematology & Oncology, University MD School of Medicine

Request appointment

22 S Greene StBaltimore, MD 21201
Book by Phone+1(443) 282-9946
Fax+1 410-328-6896

Overview of Dr. Baer

Dr. Maria Baer is an oncologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and Veterans Affairs Maryland Health Care System-Baltimore Division. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice 47 years. Dr. Baer accepts several types of health insurance, listed below. She is one of 110 doctors at University of Maryland Medical Center and one of 36 doctors at Veterans Affairs Maryland Health Care System-Baltimore Division who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Vanderbilt University Medical CenterResidency, Internal Medicine, 1979 - 1982
Johns Hopkins University School of MedicineClass of 1979

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2007 - 2026
NY State Medical License 1985 - 2008
TN State Medical License 1984 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia
COMPLETED
PHASE3
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
COMPLETED
PHASE2
Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
COMPLETED
PHASE2

Publications & Presentations

PubMed

Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Fieke W Hoff, Joshua F Zeidner, Geeta Torlapati, Deedra Nicolet, Krzysztof Mrózek
American Journal of Hematology. 2026-09-01
Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory mIDH1 AML.
Shira N Dinner, Justin M Watts, Jorge E Cortes, Jay Yang, Maria R Baer
European Journal of Haematology. 2026-08-14
Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors.
Aditi Chatterjee, Moaath K Mustafa Ali, Christopher M Bailey, Yuchen Liu, Donald Small
Leukemia. 2026-08-01

Abstracts/Posters

Association of Time to Initial Emergency Department Analgesia with Rate of Admission in Patients with Uncomplicated Sickle Cell Disease Vaso-Occlusive Crises
Maria R. Baer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E...
Maria R. Baer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Treatment-Na¥ve Patients with Higher-Risk Myelodysplastic Syndrome
Maria R. Baer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Impact of Minimal Residual Disease and Achievement of Complete Remission/Complete Remission with Partial Hematologic Recovery (CR/CRh) on Overall Survival Following Tr...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

New Drug Combination Targets Aggressive Blood CancerMarch 7th, 2017
Researchers Identify Novel Mechanism in Combination Drug Therapy for Acute Myeloid Leukemia, Other CancersOctober 11th, 2016

Grant Support

Enhancing FLT3 inhibitor efficacy in acute myeloid leukemia with FLT3-ITDBALTIMORE VA MEDICAL CENTER2021–2025

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CareFirst BCBS Maryland POS
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment